Clinical practice guidelines in nephrology - For worse or for better

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1145-1153

  Uhlig, Katrin ^a   Balk, Ethan M ^a   Lau, Joseph ^a   Levey, Andrew S ^a  

^a Tufts Center for Kidney Disease Guideline Development and Implementation   (United States)

Author keywords

Chronic kidney disease; Clinical practice guidelines; Evidence grading; Systematic review

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL SOCIETY; NEPHROLOGY; PATIENT CARE; PATIENT DECISION MAKING; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PUBLICATION; RELIABILITY; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; VALIDITY;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; NEPHROLOGY; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 33646166215     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl084     Document Type: Editorial

References (41)

1. Field MJ, Lohr KN, eds. Clinical Practice Guidelines - Directions for a New Program. National Academy Press, Washington, DC: 1990
2. Woolf SH. Practice guidelines: A new reality in medicine. I. Recent developments. Arch Int Med 1990; 150: 1811-1818
3. Wennberg JE. Understanding geographic variations in health care delivery. N Engl J Med 1999; 340: 52
4. Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): How can we improve the care of hemodialysis patients? Semin Dial 2001; 14: 157-159
5. Collins AJ, Roberts TL, St Peter WL, Chen SC, Ebben J, Constantini E. United States Renal Data System assessment of the impact of the National Kidney Foundation - Dialysis Outcomes Quality Initiative guidelines. Am J Kidney Dis 2002; 39: 784-795
6. Ashton CM, Petersen NJ, Souchek J et al. Geographic variations in utilization rates in veterans affairs hospitals and clinics. N Engl J Med 1999; 340: 32-39
7. KDOQI Disclaimer Website. Accessed 11/16/2005. http://www.kidney.org/ professionals/kdoqi/guidelines_updates/doqiup_disclaimer.html 2005
8. O'Connor PJ. Adding value to evidence-based clinical guidelines. JAMA 2005; 294: 741-743
9. Epstein AM, Lee TH, Hamel MB. Paying physicians for high-quality care. New Engl J Med 2004; 350: 406-410
10. Atkins D, Best D, Briss PA, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490
11. The AGREE Collaboration. Appraisal of Guidelines Research & Evaluation (AGREE). Instrument, Training Manual. Accessed 11/16/2005. http://www/agreecollaboration.org/pdf/agreeinstrumentfinal.pdf 2003
12. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization. Ann Inter Med 2003; 139: 493-498
13. Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999; 11: 21-28
14. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281: 1900-1905
15. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: The need for a critical appraisal. Lancet 2000; 355: 103-106
16. Schunemann HJ, Best D, Vist G, Oxman AD, GRADE Working Group. Letters, numbers, symbols and words: How to communicate grades of evidence and recommendations. CMAJ 2003; 169: 677-680
17. GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations II: A pilot study of a new system for grading the quality of evidence and the strength of recommendations. BMC Health Serv Res 2005; 5: 25
18. The periodic health examination. Canadian Task Force on the Periodic Health Examination. CMAJ 1979; 121: 1193-1254
19. Uhlig K, MacLeod A. Adoption of a modified GRADE approach for grading of KDIGO guidelines. [Abstract]. 3rd Guideline International Network (GIN) Conference 2005; Lyon, France
20. Sarnak M, Levey A, Schoolwerth A et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003; 42: 1050-1065
21. Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056
22. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for chronic kidney disease: Evaluation, classification, and stratification. American J Kidney Dis 2002; 39 [Suppl 1]: S1-S266
23. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15: 411-419
24. Eknoyan G, Levin NW, Eschbach JW et al. Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis 2001; 37: 179-194
25. Steinberg EP, Eknoyan G, Levin NW et al. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: Description, findings, and implications. Am J Kidney Dis 2000; 36: 1-11
26. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann of Intern Med 1997; 127: 380-7
27. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992; 268: 240-248
28. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: Translating evidence into action. Health Affair 2001; 20: 64-78
29. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005; 294: 218-228
30. Eknoyan G, Lameire N, Barsoum R et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310-1314
31. Kidney Disease: Improving Global Outcomes (KDIGO). Accessed 1/19/2006. http://www.kdigo.org/welcome.htm 2006
32. Murray CJ, Frenk J. A framework for assessing the performance of health systems. B World Health Organ 2000; 78: 717-731
33. Hutubessy R, Chisholm D, Edejer TT, and WHO Choice. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc 2003 Dec 19; 1(1): 8
34. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Diseases 2005; 46 [Suppl 1]: S1-S103
35. Chobanian A, Bakris G, Black H et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572
36. Drueke T, Moe S. Disturbances of bone and mineral metabolism in chronic kidney disease: An international initiative to improve diagnosis and treatment. Nephrol Dial Transplant 2004; 19: 534-536
37. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100
38. Renal Physicians Association. New ICD-9 Codes for Chronic Kidney Disease. Effective 10/1/2005. Accessed 11/18/2005. http://www.renalmd.org/documents/ICD-9RevisedCKDCodenarrative.pdf 2005
39. National Kidney Disease Education Program. Accessed 11/16/2005. www.nkdep.nih.gov 2005
40. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
41. Lohr KN, Eleazer K, Mauskopf J. Health policy issues and applications for evidence-based medicine and clinical practice guidelines. Health Policy 1998; 46: 1-19